ArticleJTO clinical and research reports2023

Clinical Outcomes of Patients With Metastatic NSCLC After Discontinuation of Immunotherapy Because of Immune-Related Adverse Effects.

Lysanne A Lievense et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.